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ISN WCN 2020, ABU DHABI, UAEResults: Out of 320 venipunctures recorded, 203 were considered for
analysis (117 - insufficient data). The mean age of patients was 4.7
years. 85 (41.9%), 85(41.9%) and 33(16.2%) procedures were done in
OPD, ED and PW respectively. General paediatrics department (n¼116,
57.1%) had most patients, followed by nephrology (n¼ 34, 16.7%) and
hematooncology (n¼ 33, 16.2%). 84/203 (41.3%) children were
suffering from chronic disease. Nurses performed 103(50.7%), followed
by phlebotomists (90 (44.3%)) and junior doctors (10(4.9%)). Only
17.2% requests had physician instruction regarding vascular access.
124 patients (61.1%) had needle stick and 79 patients (38.9%) had
cannula placed. The preferred site used for needle stick method was
cubital fossa (n¼62, 50%) followed by dorsum of hand (n¼ 60, 48.3%).
For cannula placement, 77/79 venipuncture attempts were made in
dorsum of hand. 7% of patients required more than 1 attempt to obtain
sufficient blood samples. Of 203 patients, 46 had difficult access and all
these patients (100%) who had this difficult venous access were chronic
disease patients (Kidney 50%, hematology 37.5%, endocrine 12.5% ).
Only 60% of doctors and 33.3% of phlebotomists preferred dorsum
of hand as first site.
Conclusions: Vein preservation education is lacking and should be
implemented in all hospitals. This strategy benefits childrenwith chronic
disease most, especially kidney disease. Interventions like flagging pa-
tients with chronic disease, use of wrist bands and bracelets, educating
parents/children on vein preservation can help these patients.
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Introduction: End-stage kidney disease-ESKD-patients not infrequently
develop pulmonary complications such as oedema, infection or pleurisy
and eventually need renal replacement therapy(RRT) via dialysis (either
hemodialysis or peritoneal dialysis) or kidney transplantation to survive.
Methods: This prospective study evaluated the pulmonary function
tests of patients with chronic kidney disease (CKD) and healthy donors
who attended the kidney donor clinic at the Royal Hospital. The study
was carried on during the period from Jan ’2010 till Jan “2015. All
patients have undergone Pulmonary Functions Test (PFT) at the next
day post their hemodialysis session. For statistical analysis, the STATA
12.0 software was used.
Results: FVC was 3.67(0.78) and 3.12 (0.82) for control and CKD partici-
pants, respectively, p¼0.019. FEV1 was 2.97(0.63) 2.57 (0.74) for control
and CKD participants, respectively, p¼0.043. On the other hand, the
FEV1/FVC ratio was 80.5(6.9) and 81.8(0.74) for control and CKD partici-
pants, respectively p¼0.56. Similarly, there was no significant statistical
difference regarding PEF and TLC between CKD and control participants.
The VC was 3.78(0 .73) vs 3.38 (0.55), p¼0.04 for control and CKD
participants, respectively. The ERV values were 1.41 (0.34) and 1.78
(0.48), p¼0.01 for control and CKD participants, respectively. But RV
and RV/TLC showed no statistically significant difference between
control and CKD participants, as shown in table 1.
The DLCO was 23.29 (4.77) and 18.16 (4.57), p<0.001, for control
and CKD participants, respectively. The VA for control and CKDItem Potential Kidney donor CKD -Recipient for KTX P. Value
FVC 3.67 SD 0.78 3.12 SD 0.82 0.0185
FEV1 2.97 SD 0.63 2.57 SD 0 .74 0.0434
FEV1/FVC 80.48 SD 6.92 81.79 SD 9.00 0.5605
PEF 416.89 SD 102.89 386.92 SD 105.48 0.3099
TLC 5.39 SD 2.13 5.23 SD 2.99 0.8347
VC 3.78 SD 0 .73 3.38 SD 0.55 0.0424
ERV 1.41 SD 0.34 1.78 SD 0.48 0.0122
RV 1.61 SD 2.08 1.95 SD 3.00 0.6464
RV/TLC 24.85 SD14.85 29.55 SD 16.60 0.3172
DLCO 23.29 SD 4.77 18.16 SD 4.57 0.0005
DLCO/VA 5.13 SD 0.88 4.47 SD 1.00 0.0192
DL/VA adjusted 5.13 SD 0.17 4.46 SD 1.00 0.0192
VA 4.62 SD 0 .99 4.12 SD 0.84 0.0695
IVC 2.14 SD 0.46 1.98 SD 0.61 0.3704
Kidney International Reports (2020) 5, S1–S392participants was 4.62 (0.99) and 4.12 (0.84), p¼0.06, respectively.
DLCO/VA was 5.13 (0.88) and 4.47 (1.0), p¼0.01, for control and CKD
participants, respectively. The DL/VA adjusted was 5.13(0.17) and 4.46
(1.0), p¼0.02, for control and CKD participants, respectively. But, IVC
values showed no statistically significant difference between control
and CKD participants.
Conclusions: To the best of our knowledge, this is the first paper to
compare pulmonary function tests in hemodialysis patients that being
worked up for kidney transplant with their first-degree relatives who
were worked up as their kidney donors. The findings of the present study
demonstrated that volume overload is closely associated with restrictive
and obstructive respiratory abnormalities where respiratory function
tests in patients with CKD undergoing dialysis show lower values than
those of the general population, and that patients undergoing dialysis
have greater impairment of DLCO and FVC than do their first relatives’
kidney transplant donor patients. Uremic pulmonary toxicity is likely to
be multifactorial and may differ with different patterns of CKD disease.
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Introduction: The Kingdom of Saudi Arabia has an increasing number
of patients with end-stage renal disease, with 3 main modalities used to
treat this disease mainly by hemodialysis, peritoneal dialysis and kid-
ney transplantation from living and deceased organ donors. Hemodi-
alysis being the most accessible modality of treatment, the kingdom is
taking a course of action for better patient management by outsourcing
the hemodialysis centers through private-government partnerships
with Diaverum and Davita.
Methods: Cross-sectional review of questionnaires filled-out by dialysis
centers in the kingdom. 2018 annual report of the Saudi Center for
Organ Transplantation.
Results: A total of 20,496 patients were on hemodialysis and peritoneal
dialysis in the kingdom. With 271 dialysis centers providing the patient
care and services. These Centers were distributed into 5 sectors, the
Ministry of Health (MOH) has 48% of the dialysis centers, Government
non-MOH with 9%, Private and charitable centers 20%, King Abdullah
Hemodialysis Project 2% and the outsourcing dialysis program of the
MOH Diaverum and Davita centers with 21%. The dialysis centers
distribution per region, Central region has 31%, Western 27%, Eastern
14%, Southern 18% and Northern 10%. Causes of renal failure were
mainly due to diabetic nephropathy 41.2%, hypertensive nephropathy
33% and unknown reasons 11%. Prevalence of HCV and HBsAG in
hemodialysis patients were 9% and 2.7% respectively. Out of HCV+ve
patients, 310 (12%) patients were found to be HCV PCR+ve. The inci-
dence and prevalence rate of patients on dialysis were 167 pmp and 621
pmp respectively. Kidney transplantation accounted from deceased and
living donation and transplantation has improved, with a significant
increased on living transplantation over the past 10 years. In 2018, 1011
kidneys were transplanted with 31 pmp kidney transplants, of which
86% were from living and 14% from deceased donation.
Conclusions: The kingdom is undergoing a reformation with regards to
renal replacement therapy and practices, outsourcing and partnering
with private dialysis providers which provides renal care to dialysis
patients. Improving the kingdoms kidney transplantation from living
and deceased organ donation is also a priority, with the current status
of the kingdom of Saudi Arabia being one of the most active in per-
forming living kidney donation in the region, it has also been working
to improve the deceased organ donation in the kingdom by setting up a
new standard in deceased donor detection, maintenance and follow-up
with key performance index (KPI).
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Introduction: Incidence and prevalence of ESRD population for some of
nations are regularly well published. Oman's publication on this aspect
is limited and therefore this study is made to contributing in publishing
this vital data.
Methods: This study is a secondary data analysis for the data obtained
from the ESRD register in Oman, and from the Oman annual health
reports, and relevant accessible published resources. The main mea-
surements and aim is to identify the incidence and prevalence of
Oman’s treated ESRD population (1983-2018). The year 1983 is the year
when renal care has started in Oman.
Results: The total number of patients registered on the Oman’s ESRD
register of the cental renal dialysis centre (RDC) from 1983 until 2010
was 3,524 ESRD patients distributed for the following treatments’ co-
horts; haemodialysis, 2,328 patients (66%); kidney transplant, 1,144
patients (32.5%); peritoneal dialysis, 52 patients (1.5%). The prevalence
statistics from 1998-2018 showed an overall increase in dialysis treat-
ment in Oman. The dialysis sub/population increased from 35 patients
in 1983 to 2,300 patients in 2018. The new patients registered in 1983
were 34 patients, in 1986 were 33, in 2013 were 168, in 2015 were 230,
and in 2018 were 350 patients per total population.
Conclusions: The overall results for the incidence and prevalence of
Oman'sESRDpopulation showed increase in thesefigureswhichagreewith
the global scenario and ring an alarm to undertake an urgent preventive
measure to stop the wild increase of this chronic disease incidence.
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Introduction: There is a paucity of information on the characteristics of
dialysis treated sub/population of Oman, therefore it is not known if it
had the same characteristics if compared with the same population
across the literature.
Methods: This study is a cross-sectional study aiming to describe the
dialysis sub/population characteristics in the northern region of Oman.
The participants involved were the dialysis treated patients in four
dialysis centres in the northern region of Oman (n ¼ 341 patients). The
main measurements were patient demographics, co-morbidities, risk
factors, impact of dialysis treatment on patient, and death profile.
Results: The average age of this population was 51.7 15.8 (mean SD).
There were more males (n ¼ 187¼ 54.8%) to females (n ¼ 154¼ 45.2%).
The most common co-morbidities reported by the study participants
were hypertension and diabetes combined (n ¼ 156 ¼ 32.4%). Hyper-
tension was the most common risk factor reported frequently by the
participants (14.2%). Over 80% of participants reported that dialysis
treatment had not caused them stress or worry. The death figures for
2014 and 2015 were 42 and 57 deaths per annum, respectively for the
northern region of Oman. The main reported causes of death were car-
diovascular diseases (n ¼ 41 ¼ 41.5%) and infection (n ¼ 10 ¼ 10.2%).
Conclusions: The overall results for the sub/population agree with the
data of the same sub/population in the Saudi Arabia and in the Euro-
pean countries. This research helped to know the characteristics of
sample dialysis population of Oman and so it can map the road for best
health plans and services for this sub/population.
SUN-204
APREVALENCE OF METHICILLIN-RESISTANT
STAPHYLOCOCCUS AUREUS AMONG END-
STAGE RENAL DISEASE PATIENTS
IN THE HAEMODIALYSIS UNIT AT DR.
WAHIDDIN SUDIRUHOSODO HOSPITAL
MAKASSAR, SOUTH SULAWESI – INDONESIA
ALBAAR, MT*1, Machmud, N1, Akhyar, A1, Rasyid, H1, Bakri, S1,
Hasyim, K1, Nasir, P1, Halim, R2, Katu, S1
1Hasanuddin University Internal medicine Makassar Indonesia, 2Hasa-
nuddin University Internal Medicine Makasssar IndonesiaS284Introduction: Prevalence of methicillin-resistant staphylococcus aureus
(MRSA) is steadily increasing globally. The present study was con-
ducted to determine the prevalence of MRSA among End-Stage Renal
Disease patients in the Haemodialysis unit at Dr. Wahiddin Sudir-
uhosodo Hospital Makassar, South Sulawesi – Indonesia
Methods: This is a descriptive observational study. Data was obtained
from medical records of haemodyalisis patients in Wahiddin Sudir-
ohusodo Hospital Makassar from January 2017 – December 2017. The
statistical analysis carried out was the calculation of proportion and
confidence interval (CI)
Results: The total number of dialysis patients was 671. The mean age was
49.07  13.66 years consisted of males 378 (56.3%) and females 293
(43.7%).Therewere 18patients (2,7%;95%CI: 1.5%-3.9%)of 671dialysis
patients infected byMRSA. Themedian age of haemodialysis patientswith
MRSA was 49 (18-69) years, males 9 (50%) and females 9 (50%).
Conclusions: The prevalence of MRSA colonization among End-Stage
Renal Disease patients in the Haemodialysis unit at Wahiddin Sudir-
uhosodo Hospital Makassar, South Sulawesi – Indonesia is 2.7%Kidney International Reports (2020) 5, S1–S392
